Hutch News
Two Irish microbiologists find their way, together, to Seattle
Microbiome experts Drs. Susan Bullman and Christopher Johnston join Fred Hutch
How to talk to parents about HPV vaccines
Fred Hutch public health researcher shares science-based tips to help doctors navigate crucial cancer-prevention conversations
Drs. Jeanne Ting Chowning, Denise Galloway receive Seattle AWIS awards
Honored for excellence in STEM education/outreach, science advancement and leadership
Continuing a legacy
Ahmed Diab, an inaugural winner of the Dr. Eddie Méndez Award, remembers his mentor
Drs. Davidson and Galloway elected to Academy of Arts & Science
Scientists join one of the nation's oldest learned societies
$12M NIH grant to study rare, aggressive skin cancer
Fred Hutch, UW researchers hope to improve immunotherapies for people with Merkel cell carcinoma
Drs. Denise Galloway and Hans-Peter Kiem receive endowed chairs
Paul Stephanus Memorial Endowed Chair to Galloway; Stephanus Family Endowed Chair for Cell and Gene Therapy to Kiem
Acclaimed oncologist, author, Dr. Siddhartha Mukherjee visits Fred Hutch
'If you are not preventing, curing and treating cancer, you are off target. You have not achieved the mandate.'
A focus on partnerships at Hutch/Merck summit
Research on the immune system aims to stop infectious diseases and cancer
Data drives life sciences boom in Seattle
Hutch leaders, entrepreneurs stress importance of partnerships at Life Science Innovation Northwest conference
Galloway and Hartwell to enter Washington Life Science Hall of Fame
Awards recognize power of basic research, leadership in driving advances for patients
Jump-starting innovative projects exploring pathogen-associated cancers
Pathogen-Associated Malignancies Integrated Research Center awards first round of pilot funding supporting researchers studying H. pylori, EBV and the microbiome
The latest in gynecological cancer research from the Pacific Northwest
Inaugural Northwest Gynecological Cancer Symposium brings together scientists studying ovarian, cervical and endometrial cancers
High-Risk HPV Impairs the Homologous Recombination Pathway
From the Galloway Lab, Human Biology Division
Good News: Purchase Fred Hutch vanity plates to help drive cancer research
Celebrating faculty and staff achievements
Galloway receives NCI Outstanding Investigator Award
Leader in HPV research will work to improve detection, prevention and treatment of virally caused cancers
Integrated approach to overcome pathogen-associated malignancies
Dr. Denise Galloway heads new collaborative center to study prevention and treatment of cancers linked to infectious agents
Fred Hutch aims to eliminate cancers caused by infections
Roughly 20 percent of cancers diagnosed globally each year are linked to infectious agents, with higher incidence in parts of Africa and in China
Good News: Fred Hutch epidemiologists receive $2.5M grant for first-ever study of therapeutic use for HPV vaccine
Celebrating faculty and staff achievements
Bezos family gives $35 million to Fred Hutch
‘What we are really giving is the gift of time’; funds will be invested in more world-class faculty to speed cures for cancer patients
HPV and cancer: Risks for non-HPV16 and HPV18 strains
From the Galloway and Hughes Labs (Human Biology and Vaccine and Infectious Disease Divisions)
Nearly half of U.S. men actively infected with HPV, study finds
HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated
A new blood test detects recurrence of rare skin cancer
$200 assay can accurately signal return of Merkel cell carcinoma — in some cases catching tumors earlier than expensive imaging
HPV vaccine boosts immune memory
A single dose of the HPV vaccine can strengthen immune memory in people who’ve previously been infected with HPV — and potentially help prevent re-infection